Approval · Notice of Compliance 10452 · 2009
ERAXIS: Notice of Compliance 10452
Issued July 28, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10452
- Date
- July 28, 2009
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New presentation without solvent
- Therapeutic class
- Antifungal agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ERAXIS | 02330695 | Marketed |
Medicinal ingredients
- ANIDULAFUNGIN 100 MG per VIAL